Q4 2024 Management View Chris Viehbacher, CEO, noted that Biogen is focused on three core priorities: driving growth from its four recently launched products, reprioritizing the pipeline for ...

CME Group reported better-than-expected earnings, with record revenue and EPS driven by strong asset class growth.

MetLife, Inc. is rated a buy due to its solid value, above-market dividend yield, and favorable technical chart despite ...

Ecolab Inc (NYSE:ECL) shares are trading higher after the company reported fourth-quarter sales growth of 2% year-on-year to ...

Although many of Wall Street's most-influential businesses have leaned on AI as a way to fuel their growth, one of Wall ...

Ryder projects 2025 comparable EPS in the range of $13-$14, reflecting a 17% increase at the high end. ROE is forecasted to rise to 17%-18%, supported by structural improvements and contractual ...